WallStreetZenWallStreetZen

NASDAQ: IOBT
Io Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IOBT

Based on 1 analyst offering 12 month price targets for Io Biotech Inc.
Min Forecast
$8.00+444.22%
Avg Forecast
$8.00+444.22%
Max Forecast
$8.00+444.22%

Should I buy or sell IOBT stock?

Based on 1 analyst offering ratings for Io Biotech Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IOBT stock forecasts and price targets.

IOBT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06

1 of 1

Forecast return on equity

Is IOBT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is IOBT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

IOBT revenue forecast

What is IOBT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$6.0M
Avg 2 year Forecast
$34.0M
Avg 3 year Forecast
$102.4M

IOBT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IOBT$1.47$8.00+444.22%Buy
VIGL$2.65$18.50+598.11%Hold
ANIX$3.07$12.00+290.88%Buy
ORMP$2.35N/AN/A
VANI$1.80N/AN/A
View Top Biotech Stocks

Io Biotech Stock Forecast FAQ

Is Io Biotech Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IOBT) stock is to Buy IOBT stock.

Out of 1 analyst, 0 (0%) are recommending IOBT as a Strong Buy, 1 (100%) are recommending IOBT as a Buy, 0 (0%) are recommending IOBT as a Hold, 0 (0%) are recommending IOBT as a Sell, and 0 (0%) are recommending IOBT as a Strong Sell.

If you're new to stock investing, here's how to buy Io Biotech stock.

What is IOBT's revenue growth forecast for 2025-2027?

(NASDAQ: IOBT) Io Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Io Biotech's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast IOBT's revenue for 2025 to be $395,285,484, with the lowest IOBT revenue forecast at $395,285,484, and the highest IOBT revenue forecast at $395,285,484. On average, 4 Wall Street analysts forecast IOBT's revenue for 2026 to be $2,241,729,861, with the lowest IOBT revenue forecast at $1,633,846,667, and the highest IOBT revenue forecast at $3,327,710,847.

In 2027, IOBT is forecast to generate $6,747,259,688 in revenue, with the lowest revenue forecast at $4,684,132,985 and the highest revenue forecast at $8,627,105,688.

What is IOBT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IOBT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IOBT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IOBT price target, the average IOBT price target is $8.00, with the highest IOBT stock price forecast at $8.00 and the lowest IOBT stock price forecast at $8.00.

The Wall Street analyst predicted that Io Biotech's share price could reach $8.00 by Mar 6, 2025. The average Io Biotech stock price prediction forecasts a potential upside of 444.22% from the current IOBT share price of $1.47.

What is IOBT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IOBT) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.